{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Métastase lymphatique : Questions médicales les plus fréquentes",
"headline": "Métastase lymphatique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Métastase lymphatique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-28",
"dateModified": "2025-02-22",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Métastase lymphatique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Métastase tumorale",
"url": "https://questionsmedicales.fr/mesh/D009362",
"about": {
"@type": "MedicalCondition",
"name": "Métastase tumorale",
"code": {
"@type": "MedicalCode",
"code": "D009362",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.650"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Métastase lymphatique",
"alternateName": "Lymphatic Metastasis",
"code": {
"@type": "MedicalCode",
"code": "D008207",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Yanshi Li",
"url": "https://questionsmedicales.fr/author/Yanshi%20Li",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Tao Lu",
"url": "https://questionsmedicales.fr/author/Tao%20Lu",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Guohua Hu",
"url": "https://questionsmedicales.fr/author/Guohua%20Hu",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Tianxin Lin",
"url": "https://questionsmedicales.fr/author/Tianxin%20Lin",
"affiliation": {
"@type": "Organization",
"name": "Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China. Electronic address: lintx@mail.sysu.edu.cn."
}
},
{
"@type": "Person",
"name": "Changhao Chen",
"url": "https://questionsmedicales.fr/author/Changhao%20Chen",
"affiliation": {
"@type": "Organization",
"name": "Department of Urology, Sun Yat-sen Memorial Hospital, Guangzhou, Guangdong, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "PGT-A: The biology and hidden failures of randomized control trials.",
"datePublished": "2022-07-25",
"url": "https://questionsmedicales.fr/article/35765263",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/pd.6199"
}
},
{
"@type": "ScholarlyArticle",
"name": "Statistical Power of Randomized Controlled Trials in Trauma Surgery.",
"datePublished": "2023-07-07",
"url": "https://questionsmedicales.fr/article/37417653",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/XCS.0000000000000800"
}
},
{
"@type": "ScholarlyArticle",
"name": "Predictors of premature termination and completion of randomized controlled trials.",
"datePublished": "2023-05-06",
"url": "https://questionsmedicales.fr/article/37156372",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cct.2023.107219"
}
},
{
"@type": "ScholarlyArticle",
"name": "Parachutes, randomized controlled trials, and all-cause mortality.",
"datePublished": "2022-11-25",
"url": "https://questionsmedicales.fr/article/36434291",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s40656-022-00551-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Assessing transparency practices in dental randomized controlled trials.",
"datePublished": "2024-08-24",
"url": "https://questionsmedicales.fr/article/39182028",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12874-024-02316-0"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "États, signes et symptômes pathologiques",
"item": "https://questionsmedicales.fr/mesh/D013568"
},
{
"@type": "ListItem",
"position": 3,
"name": "Processus pathologiques",
"item": "https://questionsmedicales.fr/mesh/D010335"
},
{
"@type": "ListItem",
"position": 4,
"name": "Processus néoplasiques",
"item": "https://questionsmedicales.fr/mesh/D009385"
},
{
"@type": "ListItem",
"position": 5,
"name": "Métastase tumorale",
"item": "https://questionsmedicales.fr/mesh/D009362"
},
{
"@type": "ListItem",
"position": 6,
"name": "Métastase lymphatique",
"item": "https://questionsmedicales.fr/mesh/D008207"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Métastase lymphatique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Métastase lymphatique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-19",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Métastase lymphatique",
"description": "Comment diagnostiquer une métastase lymphatique ?\nQuels tests sont utilisés pour détecter des métastases ?\nQuels signes indiquent une métastase lymphatique ?\nPeut-on détecter des métastases par analyse sanguine ?\nQuel rôle joue l'imagerie dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D008207?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Métastase lymphatique",
"description": "Quels sont les symptômes des métastases lymphatiques ?\nLes métastases lymphatiques causent-elles des douleurs ?\nPeut-on avoir des symptômes sans métastases visibles ?\nLes symptômes varient-ils selon le type de cancer ?\nComment les symptômes évoluent-ils avec le temps ?",
"url": "https://questionsmedicales.fr/mesh/D008207?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Métastase lymphatique",
"description": "Peut-on prévenir les métastases lymphatiques ?\nQuels facteurs de risque augmentent les métastases ?\nL'alimentation influence-t-elle le risque de métastases ?\nLe dépistage régulier est-il important ?\nLes vaccinations peuvent-elles aider ?",
"url": "https://questionsmedicales.fr/mesh/D008207?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Métastase lymphatique",
"description": "Quels traitements sont disponibles pour les métastases lymphatiques ?\nLa radiothérapie est-elle efficace contre les métastases ?\nQuand la chirurgie est-elle recommandée ?\nQuels médicaments sont utilisés pour traiter les métastases ?\nLes traitements sont-ils personnalisés ?",
"url": "https://questionsmedicales.fr/mesh/D008207?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Métastase lymphatique",
"description": "Quelles complications peuvent survenir avec les métastases ?\nLes métastases lymphatiques affectent-elles la fonction immunitaire ?\nComment les métastases impactent-elles la qualité de vie ?\nLes métastases peuvent-elles causer des problèmes respiratoires ?\nY a-t-il un risque d'infection avec les métastases ?",
"url": "https://questionsmedicales.fr/mesh/D008207?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Métastase lymphatique",
"description": "Quels cancers sont plus susceptibles de métastaser par voie lymphatique ?\nLe tabagisme est-il un facteur de risque ?\nL'âge influence-t-il le risque de métastases ?\nLes antécédents familiaux jouent-ils un rôle ?\nL'obésité est-elle un facteur de risque pour les métastases ?",
"url": "https://questionsmedicales.fr/mesh/D008207?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une métastase lymphatique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par imagerie (IRM, TDM) et biopsie des ganglions lymphatiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter des métastases ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'échographie, la tomographie et la scintigraphie lymphatique."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une métastase lymphatique ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un gonflement des ganglions lymphatiques et des douleurs localisées peuvent indiquer des métastases."
}
},
{
"@type": "Question",
"name": "Peut-on détecter des métastases par analyse sanguine ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les analyses sanguines peuvent révéler des marqueurs tumoraux, mais ne suffisent pas pour le diagnostic."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'imagerie dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie permet de visualiser l'étendue des métastases et d'évaluer les ganglions lymphatiques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes des métastases lymphatiques ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des ganglions enflés, douleur, fatigue et perte de poids."
}
},
{
"@type": "Question",
"name": "Les métastases lymphatiques causent-elles des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent provoquer des douleurs localisées au niveau des ganglions touchés."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans métastases visibles ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains patients peuvent présenter des symptômes sans métastases détectables par imagerie."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de cancer ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction du type de cancer primaire et de sa localisation."
}
},
{
"@type": "Question",
"name": "Comment les symptômes évoluent-ils avec le temps ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent s'aggraver avec la progression de la maladie et l'extension des métastases."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les métastases lymphatiques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par un dépistage précoce et un traitement efficace des cancers primaires."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque augmentent les métastases ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux, le tabagisme et l'obésité sont des facteurs de risque connus."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle le risque de métastases ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation saine peut réduire le risque de cancer et donc de métastases lymphatiques."
}
},
{
"@type": "Question",
"name": "Le dépistage régulier est-il important ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage régulier permet de détecter les cancers à un stade précoce, réduisant le risque de métastases."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles aider ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations, comme celles contre le HPV, peuvent réduire le risque de cancers associés."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les métastases lymphatiques ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la chirurgie, la radiothérapie et la chimiothérapie ciblée."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle efficace contre les métastases ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la radiothérapie peut réduire la taille des métastases et soulager les symptômes."
}
},
{
"@type": "Question",
"name": "Quand la chirurgie est-elle recommandée ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie est recommandée si les métastases sont localisées et accessibles sans risque majeur."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont utilisés pour traiter les métastases ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme les inhibiteurs de tyrosine kinase et l'immunothérapie sont utilisés."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements sont souvent adaptés en fonction du type de cancer et de l'état du patient."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les métastases ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'obstruction lymphatique, la douleur chronique et l'infection."
}
},
{
"@type": "Question",
"name": "Les métastases lymphatiques affectent-elles la fonction immunitaire ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent compromettre la fonction immunitaire en affectant les ganglions lymphatiques."
}
},
{
"@type": "Question",
"name": "Comment les métastases impactent-elles la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent entraîner des douleurs, une fatigue accrue et des limitations fonctionnelles."
}
},
{
"@type": "Question",
"name": "Les métastases peuvent-elles causer des problèmes respiratoires ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, si elles se propagent aux ganglions lymphatiques thoraciques, cela peut affecter la respiration."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque d'infection avec les métastases ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les métastases peuvent augmenter le risque d'infections en compromettant le système lymphatique."
}
},
{
"@type": "Question",
"name": "Quels cancers sont plus susceptibles de métastaser par voie lymphatique ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les cancers du sein, du poumon et de la peau sont souvent associés à des métastases lymphatiques."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme augmente le risque de plusieurs cancers, favorisant les métastases."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de métastases ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de métastases augmente avec l'âge en raison de la diminution de l'immunité."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de cancer augmentent le risque de développer des métastases."
}
},
{
"@type": "Question",
"name": "L'obésité est-elle un facteur de risque pour les métastases ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'obésité est associée à un risque accru de plusieurs cancers et de métastases."
}
}
]
}
]
}
Preimplantation Genetic Testing - Aneuploidy (PGT-A) for embryo selection has undergone significant advancements in the last 2 decades and yet many studies still fail to demonstrate any clinical benef...
All suitable blastocysts were biopsied and analyzed for chromosome copy number. Outcomes (positive beta hCG, implantation, ongoing pregnancy, and live birth rates) for Eu-S were compared to Mo-S using...
Compared to Eu-S embryos, Mo-S embryos resulted in significant reduction of outcomes for positive beta hCG (p = 0.0005), implantation (p = 0.0008), ongoing pregnancy (p = 0.0046), livebirth (p = 0.011...
Embryo chromosome status is central to improved embryo transfer outcomes and sole reliance on current morphology-based selection practices, without Eu-S, will always compromise outcomes. Often overloo...
Our purpose was to conduct a bibliometric study investigating the prevalence of underpowered randomized controlled trials (RCTs) in trauma surgery....
A medical librarian conducted a search of RCTs in trauma published from 2000 to 2021. Data extracted included study type, sample size calculation, and power analyses. Post hoc calculations were perfor...
In total 187 RCTs from multiple continents and 60 journals were examined. A total of 133 (71%) were found to have "positive" findings consistent with their hypothesis. When evaluating their methods, 5...
A concerningly large proportion of recently published RCTs in trauma surgery do not report a priori sample size calculations, do not meet enrollment targets, and are not adequately powered to detect e...
Randomized clinical trials (RCTs) have a key role in progressing biomedical research and guiding clinical decision making, but premature termination remains high (up to 30%), raising concerns regardin...
In 2003 and 2018 researchers discussed the perils of blind reliance on randomized controlled trials that have been substituted for medical experience and clinical acumen. Although these past articles ...
To evaluate transparency practices in randomized controlled trials (RCTs) in dentistry....
This meta-research study included RCTs in dentistry regardless of topic, methods, or level of detail reported. Only studies in English were considered. We searched PubMed for RCTs in dentistry publish...
A total of 844 RCTs were included. Only 12.86% of studies reported any information about data and code sharing. Protocol registration was reported for 50.36% of RCTs. Conflict of interest (83.41%) and...
Considering the importance of RCTs for evidence-based dentistry, it is crucial that everyone who participates in the scientific production and dissemination process actively and consistently promotes ...
The P value is a widely used measure of statistical importance but has many drawbacks and limitations, one being that it does not reflect the robustness of the results of a clinical trial. The Fragili...
We conducted a comprehensive systematic search of high-impact anesthesia, surgical, and medical journals from the last 25 years for trials comparing an intervention between two groups with a statistic...
The median [interquartile range] FI was 3 [1-7] and correlated positively with the number of participants (r...
The FI of published trials in pediatric anesthesiology is similarly low as in other medical specialties. Larger trials with more events and P values ≤ 0.01 were associated with a higher FI....
Central serous chorioretinopathy (CSCR), a common chorioretinal disease, presents with a myriad of manifestations. Acute CSCR presents with localized neurosensory detachment whereas chronic CSCR may s...
Sample size and statistical power are often limited in pediatric cardiology studies due to the relative infrequency of specific congenital malformations of the heart and specific circulatory physiolog...
Madole & Harden argue that just as the results of randomized controlled trials (RCTs) represent gains in causal knowledge and are useful, despite their limitations, so too are the findings of human be...
Randomized controlled trials (RCT) represent evidence at the lowest potential risk for bias. Clinicians in all specialties depend upon RCTs to guide patient care. Issues such as statistical discordanc...
PubMed was searched using "randomized controlled trial." Studies were selected using a random number generator. Studies were included if the primary outcome could be reproduced using the data and stat...
Overall, 572 RCTs were selected involving six specialties. Of these, 45% were positive (p<0.05) studies. Eleven (2%) published results that differed from the reproduction analysis and crossed the p=0....
Less than 5% of published RCTs reported a discordant p-value that crossed the "p=0.05" threshold. Although the occurrence is uncommon, the existence of even one RCT publishing nonreproducible results ...